On the other hand, IL-21 blockade by therapeutic administration of IL21R-Fc has been effective in other animal models of RA [62] or SLE [63], producing a reduction in clinical severity and an increase in the survival rate. The gene discussed is IL21R; the disease is systemic lupus erythematosus.